11/05/2026
Accelerate Radiopharmaceutical R&D with a Complete Precursor Building Block Platform 🧬⚛️
At Sinopeg, we’re dedicated to empowering radiopharmaceutical innovators with a comprehensive library of precursor building blocks covering all three core modules of radiopharmaceutical molecules:
🔹 Ligand (small molecules, peptides, antibodies) – for precise targeting
🔹 Linker (PEG, heterocycles, short peptides) – connecting ligand & chelator
🔹 Chelator (DOTA, DOTAGA, NOTA, PSC, etc.) – for stable radionuclide chelation
✅ GMP-grade building blocks – independently controlled
✅ Modular synthesis platform – individual or custom combinations available
✅ Tailored solutions – to significantly accelerate your early-stage R&D
Our experienced synthesis team ensures high purity and stability, e.g.:
Monodisperse PEG homolog impurities ≤0.2%, single impurity ≤1%
🔥 What truly sets us apart –
We’ve achieved stable, large-scale supply of critical precursors, backed by a robust quality research system and impurity identification/control capabilities. We provide complete cold kit services for IND filing, supporting dual filing in China and the U.S. and other global regulatory submissions.
🔄 End-to-end radiopharmaceutical precursor enablement –
From molecular design, CMC, clinical supply to commercial production – we cover the full lifecycle, leveraging precursors to boost the efficiency of hot drug development.
⏳ What makes radiopharmaceutical R&D faster?
A deep respect for both time and quality.
As one of the few CDMOs in China solely focused on radiopharmaceutical precursors, our expertise is concentrated and our services are specialized. We look forward to partnering with you!
📩 Contact us:
WeChat / Phone: +86 18050049791
Email: [email protected]
